Dietary flavonols and risk of Alzheimer dementia
Holland TM, Agarwal P, Wang Y, Leurgans SE, Bennett DA, Booth SL, Morris MC.. Neurology, 2020-01-29
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Objective To determine whether dietary intake of flavonols is associated with Alzheimer dementia. Methods The study was conducted among 921 participants of the Rush Memory and Aging Project (MAP), an ongoing community-based, prospective cohort. Participants completed annual neurologic evaluations and dietary assessments using a validated food frequency questionnaire. Results Among 921 MAP participants who initially had no dementia in the analyzed sample, 220 developed Alzheimer dementia. The mean age of the sample was 81.2 years (SD 7.2), with the majority (n = 691, 75%) being female. Participants with the highest intake of total flavonols had higher levels of education and more participation in physical and cognitive activities. In Cox proportional hazards models, dietary intakes of flavonols were inversely associated with incident Alzheimer dementia in models adjusted for age, sex, education, APOE ɛ4, and participation in cognitive and physical activities. Hazard ratios (HRs) for the fifth vs first quintiles of intake were as follows: for total flavonol, 0.52 (95% confidence interval [CI], 0.33-0.84); for kaempferol, 0.49 (95% CI, 0.31-0.77); for myricetin, 0.62 (95% CI, 0.4-0.97); and for isorhamnetin, 0.62 (95% CI, 0.39-0.98). Quercetin was not associated with Alzheimer dementia (HR, 0.69; 95% CI, 0.43-1.09). Conclusion Higher dietary intakes of flavonols may be associated with reduced risk of developing Alzheimer dementia.
What this study adds
Evidence grade: Moderate
This is a follow-up (cohort) study of 691 participants. Among 921 participants, higher dietary intakes of total flavonols, kaempferol, myricetin, and isorhamnetin were associated with lower incidence of Alzheimer dementia, while quercetin was not associated. This is an observational association and does not prove that flavonols prevent or treat Alzheimer's disease.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Holland, T. M., Agarwal, P., Wang, Y., Leurgans, S. E., Bennett, D. A., Booth, S. L., et al. (2020). Dietary flavonols and risk of Alzheimer dementia. Neurology. https://doi.org/10.1212/wnl.0000000000008981
Vancouver
Holland TM, Agarwal P, Wang Y, Leurgans SE, Bennett DA, Booth SL, et al. Dietary flavonols and risk of Alzheimer dementia. Neurology. 2020. doi:10.1212/wnl.0000000000008981. PMID: 31996451.
BibTeX
@article{holland2020-31996451,
author = {Holland, T. M. and Agarwal, P. and Wang, Y. and Leurgans, S. E. and Bennett, D. A. and Booth, S. L. and Morris, M. C.},
title = {{Dietary flavonols and risk of Alzheimer dementia}},
journal = {Neurology},
year = {2020},
doi = {10.1212/wnl.0000000000008981},
pmid = {31996451},
url = {https://doi.org/10.1212/wnl.0000000000008981}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 7 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- Objective To determine whether dietary intake of flavonols is associated with Alzheimer dementia.
- Results Among 921 MAP participants who initially had no dementia in the analyzed sample, 220 developed Alzheimer dementia.
- In Cox proportional hazards models, dietary intakes of flavonols were inversely associated with incident Alzheimer dementia in models adjusted for age, sex, education, APOE ɛ4, and participation in cognitive and physical activities.
- Quercetin was not associated with Alzheimer dementia (HR, 0.69; 95% CI, 0.43-1.09).
- Conclusion Higher dietary intakes of flavonols may be associated with reduced risk of developing Alzheimer dementia.
Why it matters
Among 921 participants, higher dietary intakes of total flavonols, kaempferol, myricetin, and isorhamnetin were associated with lower incidence of Alzheimer dementia, while quercetin was not associated. This is an observational association and does not prove that flavonols prevent or treat Alzheimer's disease.
New to this subject? Start with our plain-English guide: Genetics →
Study details
- Study designprospective cohort
- Participants691
- Evidence strengthModerate
How this study scored 65/100
Published in a leading specialty journal, and it is a prospective cohort study, followed forward from enrollment. Scored zero for effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (Neurology) |
| Journal's citation record | 4 / 4 | Neurology: journal h-index 525 (OpenAlex, 2026-10-29) |
| Study design | 7 / 12 | A prospective cohort study, followed forward from enrollment |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 2 / 5 | 2020 — within 10 year(s) of the newest study here |
| Sample size | 2 / 4 | 691 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 5 / 7 | Cited 187 times (OpenAlex, 2026-10-10) |
| Citations per year | 4 / 5 | 23.4 citations a year over 8 year(s) since 2020 |
| Impact for its field and year | 4 / 6 | Cited 18.6× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 2 / 6 | Cited by 3 other studies in this library |
| Still being cited | 3 / 4 | Cited 71 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Martha Clare Morris: h-index 69 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | Tufts University: institution h-index 1,045 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 3 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 31996451) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 65 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1212/wnl.0000000000008981
- PubMed: 31996451
- Original source →
- Free full text: PubMed Central →
Full text: free to read — PubMed Central lists this copy as free to read: the link above (checked 10 Oct 2026).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
3 studies in the alzhub library list this one in their references.
Related studies in Genetics from nearby years
Also tagged “biobank”
1,084 studies in the library carry the topic tag “biobank”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,084 tagged studies.